Growth Metrics

Pacific Biosciences Of California (PACB) Cash from Investing Activities (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Pacific Biosciences Of California 481.66 Mn 205.70 Mn 12.84 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 37.77%
Dec 31, 2025 37.71%
Sep 30, 2025 -25.24%
Jun 30, 2025 -44.11%
Mar 31, 2025 -22.33%
Dec 31, 2024 152.50%
Sep 30, 2024 -69.98%
Jun 30, 2024 325.09%
Mar 31, 2024 48.73%
Dec 31, 2023 -127.47%
Sep 30, 2023 345.79%
Jun 30, 2023 -35.89%
Mar 31, 2023 -190.24%
Dec 31, 2022 49.15%
Sep 30, 2022 189.43%
Jun 30, 2022 -243.35%
Mar 31, 2022 -36.04%
Jun 30, 2021 -5,740.24%
Mar 31, 2021 108.29%
Dec 31, 2020 -54.77%
Sep 30, 2020 -2,125.99%
Jun 30, 2020 94.74%
Mar 31, 2020 -1,494.10%
Dec 31, 2019 -117.34%
Sep 30, 2019 151.65%
Jun 30, 2019 -79.43%
Mar 31, 2019 788.99%
Dec 31, 2018 85.24%
Sep 30, 2018 -406.32%
Jun 30, 2018 257.32%
Mar 31, 2018 -172.56%
Dec 31, 2017 118.72%
Sep 30, 2017 111.46%
Jun 30, 2017 -267.16%
Mar 31, 2017 281.89%
Dec 31, 2016 -38.59%
Sep 30, 2016 218.61%
Jun 30, 2016 60.59%
Mar 31, 2016 -3.62%
Dec 31, 2015 -253.98%
Sep 30, 2015 1,145.04%
Jun 30, 2015 -92.35%
Mar 31, 2015 1,113.85%
Dec 31, 2014 -111.89%
Sep 30, 2014 6,992.74%
Jun 30, 2014 -97.82%
Mar 31, 2014 133.94%
Dec 31, 2013 -741.83%
Sep 30, 2013 152.67%
Jun 30, 2013 -27.98%
Mar 31, 2013 -117.34%
Dec 31, 2012 102.52%
Sep 30, 2012 2,139.58%
Jun 30, 2012 -94.53%
Mar 31, 2012 -17.86%
Dec 31, 2011 -31.55%
Sep 30, 2011 1,013.78%
Jun 30, 2011 91.55%
Mar 31, 2011 65.82%
Dec 31, 2010 -3,385.15%